20 Years of Leadership, 4 Areas of Transplant Innovation

Our understanding of transplant patients and care teams allows us to develop solutions to extend graft life. With two decades of commitment to transplant care, we have developed close partnerships across the transplant ecosystem that grow stronger every day.

TESTING SERVICES

  • Launched first commercial product, AlloMap® Heart, in 2005, now used by over 90% of U.S. transplant centers
  • Launched second surveillance product, AlloSure®, in 2017, using dd-cfDNA to determine graft injury
  • Ushering in the next generation in transplant management by leading the shift to multi-modality testing with HeartCare®, KidneyCareTM, HistoMap, and UroMap

TRANSPLANT LAB PRODUCTS

Through a series of acquisitions in the 2010s, built portfolio of HLA typing solutions for matching donor organs with recipients

DIGITAL TRANSPANT SOLUTIONS

In 2019, acquired Ottr® and XynManagement to expand portfolio into software and services supporting transplant centers

PHARMA SERVICES

Our latest area of innovation, we are leveraging our core technologies to help biopharma companies accelerate clinical development